vs
BlackSky Technology Inc.（BKSY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是BlackSky Technology Inc.的2.0倍（$69.8M vs $35.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -2.5%，领先386.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 15.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 20.5%）
BlackSky Technology Inc.是一家领先的地理空间情报服务商，运营高重访率小型地球观测卫星星座，为全球政府、国防、关键基础设施及商业客户提供实时卫星影像、高级数据分析与动态监测解决方案，助力各类场景下的运营决策。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BKSY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的2.0倍
$35.2M
营收增速更快
RIGL
高出5.2%
15.9%
净利率更高
RIGL
高出386.5%
-2.5%
两年增速更快
RIGL
近两年复合增速
20.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $69.8M |
| 净利润 | $-868.0K | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -11.8% | 33.2% |
| 净利率 | -2.5% | 384.0% |
| 营收同比 | 15.9% | 21.2% |
| 净利润同比 | 95.5% | 1769.2% |
| 每股收益（稀释后） | $0.04 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKSYRIGL
| Q4 25 | $35.2M | $69.8M | ||
| Q3 25 | $19.6M | $69.5M | ||
| Q2 25 | $22.2M | $101.7M | ||
| Q1 25 | $29.5M | $53.3M | ||
| Q4 24 | $30.4M | $57.6M | ||
| Q3 24 | $22.5M | $55.3M | ||
| Q2 24 | $24.9M | $36.8M | ||
| Q1 24 | $24.2M | $29.5M |
净利润BKSYRIGL
| Q4 25 | $-868.0K | $268.1M | ||
| Q3 25 | $-15.3M | $27.9M | ||
| Q2 25 | $-41.2M | $59.6M | ||
| Q1 25 | $-12.8M | $11.4M | ||
| Q4 24 | $-19.4M | $14.3M | ||
| Q3 24 | $-12.6M | $12.4M | ||
| Q2 24 | $-9.4M | $-1.0M | ||
| Q1 24 | $-15.8M | $-8.2M |
毛利率BKSYRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BKSYRIGL
| Q4 25 | -11.8% | 33.2% | ||
| Q3 25 | -85.8% | 40.9% | ||
| Q2 25 | -62.8% | 60.1% | ||
| Q1 25 | -40.5% | 23.9% | ||
| Q4 24 | -20.0% | 28.9% | ||
| Q3 24 | -58.7% | 25.4% | ||
| Q2 24 | -47.0% | 1.2% | ||
| Q1 24 | -54.7% | -23.6% |
净利率BKSYRIGL
| Q4 25 | -2.5% | 384.0% | ||
| Q3 25 | -78.2% | 40.2% | ||
| Q2 25 | -185.8% | 58.6% | ||
| Q1 25 | -43.4% | 21.5% | ||
| Q4 24 | -63.9% | 24.9% | ||
| Q3 24 | -55.8% | 22.5% | ||
| Q2 24 | -37.7% | -2.8% | ||
| Q1 24 | -65.2% | -27.9% |
每股收益（稀释后）BKSYRIGL
| Q4 25 | $0.04 | $14.11 | ||
| Q3 25 | $-0.44 | $1.46 | ||
| Q2 25 | $-1.27 | $3.28 | ||
| Q1 25 | $-0.42 | $0.63 | ||
| Q4 24 | $-0.61 | $0.82 | ||
| Q3 24 | $-0.66 | $0.70 | ||
| Q2 24 | $-0.52 | $-0.06 | ||
| Q1 24 | $-0.88 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $155.0M |
| 总债务越低越好 | $201.1M | $52.5M |
| 股东权益账面价值 | $94.9M | $391.5M |
| 总资产 | $386.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 2.12× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BKSYRIGL
| Q4 25 | $124.5M | $155.0M | ||
| Q3 25 | $146.5M | $137.1M | ||
| Q2 25 | $93.8M | $108.4M | ||
| Q1 25 | $75.8M | $77.1M | ||
| Q4 24 | $52.5M | $77.3M | ||
| Q3 24 | $63.2M | $61.1M | ||
| Q2 24 | $41.2M | $49.1M | ||
| Q1 24 | $35.4M | $49.5M |
总债务BKSYRIGL
| Q4 25 | $201.1M | $52.5M | ||
| Q3 25 | $195.1M | $60.0M | ||
| Q2 25 | $122.5M | $60.0M | ||
| Q1 25 | $115.3M | $60.0M | ||
| Q4 24 | $107.7M | $60.0M | ||
| Q3 24 | $98.8M | $60.0M | ||
| Q2 24 | $108.6M | $60.0M | ||
| Q1 24 | $85.0M | $60.0M |
股东权益BKSYRIGL
| Q4 25 | $94.9M | $391.5M | ||
| Q3 25 | $91.1M | $117.6M | ||
| Q2 25 | $86.6M | $81.9M | ||
| Q1 25 | $88.8M | $18.6M | ||
| Q4 24 | $94.0M | $3.3M | ||
| Q3 24 | $110.3M | $-14.6M | ||
| Q2 24 | $76.5M | $-29.9M | ||
| Q1 24 | $81.7M | $-31.7M |
总资产BKSYRIGL
| Q4 25 | $386.2M | $513.6M | ||
| Q3 25 | $380.9M | $242.5M | ||
| Q2 25 | $310.8M | $206.7M | ||
| Q1 25 | $284.9M | $176.0M | ||
| Q4 24 | $254.1M | $164.0M | ||
| Q3 24 | $245.5M | $139.4M | ||
| Q2 24 | $224.3M | $128.4M | ||
| Q1 24 | $210.1M | $126.5M |
负债/权益比BKSYRIGL
| Q4 25 | 2.12× | 0.13× | ||
| Q3 25 | 2.14× | 0.51× | ||
| Q2 25 | 1.41× | 0.73× | ||
| Q1 25 | 1.30× | 3.23× | ||
| Q4 24 | 1.15× | 18.25× | ||
| Q3 24 | 0.90× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | 1.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BKSYRIGL
| Q4 25 | $-9.3M | $22.0M | ||
| Q3 25 | $-39.0M | $24.0M | ||
| Q2 25 | $-7.3M | $30.5M | ||
| Q1 25 | $27.2M | $-893.0K | ||
| Q4 24 | $-1.8M | $14.5M | ||
| Q3 24 | $1.0M | $21.7M | ||
| Q2 24 | $-1.8M | $302.0K | ||
| Q1 24 | $-3.8M | $-5.0M |
现金转化率BKSYRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
